VIDAS Kube
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FDA OFFICE OF ACQ GRANT SVCS
Contract Value
Not provided
Codes & Classification
Solicitation Number
FDA-RFQ-134685
NAICS
334516 - Analytical Laboratory Instrument Manufacturing
Classification Code
6640
Additional Details
Documents2
The U.S. Food and Drug Administration (FDA), through its Office of Acquisition and Grant Services, has issued a Combined Synopsis/Solicitation for the procurement of a VIDAS Kube automated immunoassay system. This acquisition is intended to directly support the research, method development, and validation activities conducted by the Office of Applied Microbiology and Technology (OAMT), specifically within the Division of Food and Environmental Safety (DFES), Microbial Methods Development Branch (MMDB). The VIDAS Kube system will play a critical role in advancing the FDA’s capabilities in analytical testing, particularly in the context of food and environmental safety.
The scope of this procurement centers on the delivery and installation of the VIDAS Kube automated immunoassay system at the FDA’s facility located in College Park, Maryland. The system is expected to enhance the agency’s laboratory infrastructure, enabling more efficient and reliable immunoassay analyses that underpin regulatory science and public health initiatives. The intended outcome is to bolster the FDA’s capacity for microbial method development and validation, supporting its mission to safeguard food and environmental safety.
Key requirements for this opportunity include the provision of a fully functional VIDAS Kube system, compliant with the standards of analytical laboratory instrument manufacturing as defined by NAICS Code 334516 (2022 version). The procurement is classified under Product Service Code 6640, which pertains to laboratory equipment and supplies. Contractors should ensure that their offerings meet the technical specifications necessary for advanced immunoassay automation and are suitable for integration into a federal research laboratory environment.
The contracting entity for this solicitation is the FDA Office of Acquisition and Grant Services, operating under the Department of Health and Human Services. The primary point of contact for this opportunity is Roosevelt Walker, who can be reached via email at [email protected] for any inquiries or clarifications regarding the solicitation.
This procurement is being conducted as a Combined Synopsis/Solicitation, streamlining the process for interested vendors. The notice is currently active, with a posting date of August 10, 2026, and a response deadline of August 17, 2026. Contractors are encouraged to review the solicitation details and attachments available on SAM.gov (Opportunity ID: 5db195c1e8ee4751b1f8aaa76da2dfff) to ensure full compliance with submission requirements.
No set-aside requirements or special considerations have been specified in the provided information. The place of performance is College Park, Maryland, and the opportunity is open to qualified vendors capable of delivering the required immunoassay system within the United States.
In summary, this procurement represents a strategic investment by the FDA in laboratory automation technology to support its ongoing research and regulatory functions. Contractors with expertise in analytical laboratory instrument manufacturing and immunoassay systems are encouraged to evaluate this opportunity for alignment with their capabilities and submit responsive proposals by the designated deadline.